EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation

Guangrui Chen iD, Jian Li, Huimeng Liu, Huiyu Zhou, Mingqiu Liu, Di Liang iD, Zhiyun Meng, Hui Gan, Zhuona Wu, Xiaoxia Zhu, Peng Han, Taoyun Liu und 3 weitere

Molecules · 2023

DOI: 10.3390/molecules28020753 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Guangrui Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China. Hauptthemen laut MEDLINE: COVID-19, Pulmonary Fibrosis. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing municipal natural science foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary fibrosis (PF) is one of the sequelae of Corona Virus Disease 2019 (COVID-19), and currently, lung transplantation is the only viable treatment option. Hence, other effective treatments are urgently required. We investigated the therapeutic effects of an approved botanical drug, cepharanthine (CEP), in a cell culture model of transforming growth factor-β1 (TGF-β1) and bleomycin (BLM)-induced pulmonary fibrosis rat models both in vitro and in vivo. In this study, CEP and pirfenidone (PFD) suppressed BLM-induced lung tissue inflammation, proliferation of blue collagen fibers, and damage to lung structures in vivo. Furthermore, we also found increased collagen deposition marked by α-smooth muscle actin (α-SMA) and Collagen Type I Alpha 1 (COL1A1), which was significantly alleviated by the addition of PFD and CEP. Moreover, we elucidated the underlying mechanism of CEP against PF in vitro. Various assays confirmed that CEP reduced the viability and migration and promoted apoptosis of myofibroblasts. The expression levels of myofibroblast markers, including COL1A1, vimentin, α-SMA, and Matrix Metallopeptidase 2 (MMP2), were also suppressed by CEP. Simultaneously, CEP significantly suppressed the elevated Phospho-NF-κB p65 (p-p65)/NF-κB p65 (p65) ratio, NOD-like receptor thermal protein domain associated protein 3 (NLRP3) levels, and elevated inhibitor of NF-κB Alpha (IκBα) degradation and reversed the progression of PF. Hence, our study demonstrated that CEP prevented myofibroblast activation and treated BLM-induced pulmonary fibrosis in a dose-dependent manner by regulating nuclear factor kappa-B (NF-κB)/ NLRP3 signaling, thereby suggesting that CEP has potential clinical application in pulmonary fibrosis in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Pulmonary FibrosisAnimalsRatsBleomycinCollagenFibroblastsInflammationLungMyofibroblastsNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinTransforming Growth Factor beta1BenzylisoquinolinesBenzodioxoles

Stichwörter der Autor:innen

COVID-19NF-κB/NLRP3cepharanthinemyofibroblastpulmonary fibrosis

Substanzen

BleomycinCollagenNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinTransforming Growth Factor beta1cepharanthineBenzylisoquinolinesBenzodioxolesNlrp3 protein, rat

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.

ORCID-Profile: Guangrui Chen, Di Liang

Förderung

  • Beijing municipal natural science foundation

Zitieren

APA

Chen, G., Li, J., Liu, H., Zhou, H., Liu, M., Liang, D., Meng, Z., Gan, H., Wu, Z., Zhu, X., Han, P., Liu, T., Gu, R., Liu, S., & Dou, G. (2023). Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation. Molecules. https://doi.org/10.3390/molecules28020753

Vancouver

Chen G, Li J, Liu H, Zhou H, Liu M, Liang D, et al. Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation. Molecules. 2023. doi:10.3390/molecules28020753

BibTeX
@article{Chen2023,
  author = {Chen, Guangrui and Li, Jian and Liu, Huimeng and Zhou, Huiyu and Liu, Mingqiu and Liang, Di and Meng, Zhiyun and Gan, Hui and Wu, Zhuona and Zhu, Xiaoxia and Han, Peng and Liu, Taoyun and Gu, Ruolan and Liu, Shuchen and Dou, Guifang},
  title = {Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28020753}
}
Kostenlos starten →